Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction

Recruiting Observational Study
Infertility
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Study type
Observational
Participants needed
1,200 (estimated)
Sponsor
University of Luebeck · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Rationale: The hormone progesterone has different functions. In pregnancy, it is vital for maintenance thereof. In early pregnancy, progesterone is synthesized by the Corpus luteum (CL). Its production shifts from the CL to the placenta after several gestational weeks. This process is termed luteoplacental shift. Still, the exact time point of the luteoplacental shift remains unknown. Furthermore…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients aged 18 to 45 years 2. Transfer of cryopreserved embryos Exclusion Criteria: 1. Fresh IVF/ICSI embryo transfer cycle 2. Evidence for ovulation on ultrasound previous to embryo transfer confirmed by a follicle ≥14mm or by a progesterone ≥1.0 µg/l in programmed cycle…
Contacts

Georg Griesinger, MD

+49451 50577810

georg.griesinger@uni-luebeck.de

CONTACT

Tanja Eggersmann, MD

+49451 50577810

tanja.eggersmann@uksh.de

CONTACT